☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

NICE Guidance - May 2017

The National Institute of Health and Care Excellence (NICE) have published new or updated guidance for the month of May 2017. This month there are two guidelines that impact upon primary care.

The Type 2 diabetes in adults guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels and identifying and managing long-term complications. It has been updated to include sodium–glucose cotransporter 2 (SGLT-2) inhibitors in the section on drug treatment and the algorithm for blood glucose lowering therapy has been also updated to include these treatment options.

The Eating disorders: recognition and treatment guideline covers the assessment, treatment, monitoring and inpatient care for children, young people and adults with eating disorders. It aims to improve the care people receive by detailing the most effective treatments for anorexia nervosa, binge eating disorder and bulimia nervosa. The guideline includes recommendations on identifying eating disorders.

Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.

Share 'NICE Guidance - May 2017' by emailShare 'NICE Guidance - May 2017' on FacebookShare 'NICE Guidance - May 2017' on TwitterShare 'NICE Guidance - May 2017' on LinkedInShare 'NICE Guidance - May 2017' on reddit


No Comments to “NICE Guidance - May 2017”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.